Data / New clinical trials / Arthritis, Rheumatoid
Arthritis, Rheumatoid trials: 302 new since Nov 2024
The full list. New Arthritis, Rheumatoid clinical trials: 302 rows for $15.10, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 15 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/arthritis-rheumatoid, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
302 clinical studies in Arthritis, Rheumatoid were first posted on ClinicalTrials.gov from November 13, 2024 to November 6, 2026; 84 have an industry sponsor and 221 are recruiting or about to. The newest, NCT07923747, was posted on November 6, 2026: An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With... (Novartis Pharmaceuticals).
The request: Every new Arthritis, Rheumatoid clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 302New trials
- 84Industry sponsored
- 221Recruiting or not yet
- November 6, 2026Latest posted
Newest trials
The newest 100 of 302, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 6, 2026 | NCT07923747 | An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE) | Novartis Pharmaceuticals | Phase 1 | Not yet recruiting | Rheumatoid Arthritis and Systemic Lupus Erythematosus | 90 | clinicaltrials.gov | |
| November 4, 2026 | NCT07916623 | Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis | Ege University | Observational | Active not recruiting | Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Urinary Incontinence (UI) | 393 | Turkey (Türkiye) | clinicaltrials.gov |
| November 4, 2026 | NCT07914907 | GenAI-Assisted Rheumatoid Arthritis Bone Erosion Risk Assessment and DMARD Selection | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Not applicable | Recruiting | Rheumatoid Arthritis | 100 | China | clinicaltrials.gov |
| November 3, 2026 | NCT07913256 | The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development... | University Hospital, Limoges | Observational | Not yet recruiting | Rheumatoid Arthritis (RA), Lung Neoplasms | 136 | clinicaltrials.gov | |
| October 30, 2026 | NCT07906145 | A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases | Shanghai Qilu Pharmaceutical Research and Development Center LTD | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA), Primary Sjögren's Syndrome (pSS), Systemic Sclerosis (SSc) | 76 | clinicaltrials.gov | |
| October 29, 2026 | NCT07905651 | Effects of Paraffin Wax Therapy and Dry Cupping on Pain and Wrist Function in Patients With Rheumatoid Arthritis | University of Baghdad | Not applicable | Not yet recruiting | Rheumatic Arthritis | 100 | Iraq | clinicaltrials.gov |
| October 29, 2026 | NCT07904754 | Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis | AbbVie | Phase 2 | Not yet recruiting | Rheumatoid Arthritis | 250 | clinicaltrials.gov | |
| October 28, 2026 | NCT07901764 | MYTP01 for Immune-Mediated Diseases | Zhejiang Provincial People's Hospital | Not applicable | Not yet recruiting | IgA Nephropathy, Kidney Transplant Recipients, Lupus Nephritis, Primary Membranous Nephropathy, ANCA-associated... | 160 | China | clinicaltrials.gov |
| October 28, 2026 | NCT07901309 | Efficacy and Safety of Dapagliflozin as an Adjunct to Conventional Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid... | Tanta University | Phase 1/2 | Not yet recruiting | Rheumatoid Arthritis (RA | 100 | Egypt | clinicaltrials.gov |
| October 26, 2026 | NCT07895524 | A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004) | Merck Sharp & Dohme LLC | Phase 2 | Not yet recruiting | Rheumatoid Arthritis | 60 | clinicaltrials.gov | |
| October 16, 2026 | NCT07878975 | HRV Variation in Rheumatoid Arthritis | University of Central Florida | Observational | Recruiting | Rheumatoid Arthritis (RA) | 30 | United States | clinicaltrials.gov |
| October 16, 2026 | NCT07878611 | Musclockeletal Ultra-sound Assessment of Pulley Inflammation in Rheumatoid Arthrits Pateints | Sohag University | Observational | Not yet recruiting | Rheumatoid Arthritis (RA) | 80 | clinicaltrials.gov | |
| October 14, 2026 | NCT07873931 | A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases | Bristol-Myers Squibb | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic... | 60 | Belgium, France, Germany, Netherlands, Poland, United States | clinicaltrials.gov |
| October 13, 2026 | NCT07871578 | Experiences and Care Pathways Shared on Social Media Regarding 5 Conditions Causing Chronic Pain | Central Hospital, Nancy, France | Observational | Completed | Lyme Borreliosis, Fibromyalgia, Rheumatoid Arthritis (RA), Post Acute COVID 19 Syndrome, Endometriosis | 501 | France | clinicaltrials.gov |
| October 13, 2026 | NCT07870564 | the Effect and Mechanism of Percutaneous Auricular Electrical Stimulation in Preventing Central Sensitization Pain in Patients With... | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Not applicable | Not yet recruiting | Rheumatoid Arthritis (RA), Transcutaneous Vagus Nerve Stimulation | 124 | clinicaltrials.gov | |
| October 8, 2026 | NCT07865390 | Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis | Northwestern University | Not applicable | Not yet recruiting | Arthritis, Psoriatic (PsA), Arthritis, Rheumatoid (RA) | 160 | United States | clinicaltrials.gov |
| October 8, 2026 | NCT07864688 | Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patients With Rheumatoid Arthritis | Al-Azhar University | Phase 2 | Not yet recruiting | Rheumatoid Arthritis (RA) | 90 | Egypt | clinicaltrials.gov |
| October 5, 2026 | NCT07857993 | DETECTRA: Remote Monitoring to Detect Rheumatoid Arthritis Flares and Treatment Response | Centre Hospitalier Universitaire Vaudois | Not applicable | Not yet recruiting | Rheumatic Disorder, Rheumatoid Arthritis (RA) | 320 | Austria, Germany | clinicaltrials.gov |
| September 30, 2026 | NCT07849673 | Improving ILD Screening in Patients With RA and SSc Using EHR-Embedded CDS and PRO Tools | Foundation for Advancing Science Technology Education and Research | Not applicable | Not yet recruiting | Rheumatoid Arthritis (RA), SSc-Systemic Sclerosis | 800 | clinicaltrials.gov | |
| September 28, 2026 | NCT07844564 | Effects of Nonsurgical Periodontal Treatment on GCF Calprotectin and IL-10 in Rheumatoid Arthritis | Ondokuz Mayıs University | Not applicable | Completed | Rheumatoid Arthritis (RA), Periodontitis, Gingivitis | 54 | Turkey (Türkiye) | clinicaltrials.gov |
| September 24, 2026 | NCT07839221 | Combined Growth Differentiation Factor-15 (GDF-15) and Lung Ultrasound for ILD Screening in Rheumatoid Arthritis and Systemic Sclerosis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Interstitial Lung Disease (ILD) | 110 | clinicaltrials.gov | |
| September 21, 2026 | NCT07829497 | Pain Phenotyping of Rheumatic Diseases - An Observational Study | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Observational | Recruiting | Rheumatic Diseases, Lupus Erythematosus, Systemic, Lupus Vasculitis, Central Nervous System, Arthritis... | 225 | United States | clinicaltrials.gov |
| September 18, 2026 | NCT07828080 | Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis Stem | Seoul National University Bundang Hospital | Not applicable | Recruiting | Osteoarthritis, Hip, Femur Head Necrosis, Femoral Neck Fractures, Arthritis Rheumatoid, Developmental Dysplasia of Hip... | 210 | South Korea | clinicaltrials.gov |
| September 17, 2026 | NCT07825233 | Pix-Risk: Early Detection of Rheumatoid Arthritis Via the DETECTRA Platform | Centre Hospitalier Universitaire Vaudois | Not applicable | Not yet recruiting | Rheumatoid Arthritis (RA | 142 | Austria, Denmark, Germany, Switzerland | clinicaltrials.gov |
| September 11, 2026 | NCT07814989 | Wrist Nerve Block as a New Treatment in Patients With Rheumatoid Arthritis | Sohag University | Not applicable | Not yet recruiting | Rhematoid Arthritis | 180 | Egypt | clinicaltrials.gov |
| September 9, 2026 | NCT07810569 | Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients | Assiut University | Observational | Not yet recruiting | Meibomian Gland Dysfunction, Dry Eye Syndromes, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome... | 150 | clinicaltrials.gov | |
| September 4, 2026 | NCT07805109 | Subclinical Renal Dysfunction in Rheumatoid Arthritis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis, Renal Dysfunction, Chronic Kidney Diseases | 120 | clinicaltrials.gov | |
| September 3, 2026 | NCT07802678 | Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors | Sint Maartenskliniek | Phase 4 | Recruiting | Rheumatoid Arthritis (RA) | 202 | Netherlands | clinicaltrials.gov |
| September 3, 2026 | NCT07801261 | Evaluation of Functional Disability in Rheumatoid Arthritis Patients | Sohag University | Observational | Not yet recruiting | Rheumatoid Arthritis (RA) | 150 | clinicaltrials.gov | |
| September 2, 2026 | NCT07800871 | FT839 in Autoimmune Diseases | Fate Therapeutics | Phase 1/2 | Recruiting | ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA), Systemic Lupus... | 446 | United States | clinicaltrials.gov |
| September 2, 2026 | NCT07800351 | Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis | Tanta University | Phase 3 | Not yet recruiting | Rheumatoid Arthritis (RA, Atherosclerosis | 46 | Egypt | clinicaltrials.gov |
| September 1, 2026 | NCT07796841 | GAS5 Gene Expression and IL-6 in Rheumatoid Arthritis | Sohag University | Observational | Not yet recruiting | RA - Rheumatoid Arthritis | 50 | clinicaltrials.gov | |
| September 1, 2026 | NCT07796516 | Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis | Peking University People's Hospital | Phase 2 | Recruiting | Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis | 420 | China | clinicaltrials.gov |
| August 31, 2026 | NCT07793786 | Subclinical Hypothyroidism and Disease Activity in Rheumatoid Arthritis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis, Subclinical Hypothyroidism, Thyroid Dysfunction | 150 | clinicaltrials.gov | |
| August 31, 2026 | NCT07793747 | Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis, Metabolic Syndrome, Cardiovascular Diseases | 75 | clinicaltrials.gov | |
| August 24, 2026 | NCT07782788 | Predictors of Cardiac Arrhythmia in Rheumatoid Arthritis Patients | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis (RA) | 120 | clinicaltrials.gov | |
| August 24, 2026 | NCT07782450 | A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases | Pfizer | Phase 1/2 | Not yet recruiting | Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis, Systemic Sclerosis | 54 | clinicaltrials.gov | |
| August 21, 2026 | NCT07779616 | Study of PTC844 in Participants With Active Rheumatoid Arthritis | PTC Therapeutics | Phase 2 | Recruiting | Rheumatoid Arthritis | 75 | Georgia, Mauritius, South Africa, United States | clinicaltrials.gov |
| August 19, 2026 | NCT07774507 | Twenty-four Hour Movement Behaviors and Atherosclerotic Risk | São Paulo State University | Observational | Recruiting | Cardiovascular Risk Assessment, Rheumatoid Arthritis (RA), 24-Hour Movement Guidelines | 150 | Brazil | clinicaltrials.gov |
| August 19, 2026 | NCT07772687 | Prospective Analysis of Blood Flow Restriction Training in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Compared to... | University of Bonn | Not applicable | Completed | Rheumatoid Arthritis, Psoriatic Arthritis | 102 | Germany | clinicaltrials.gov |
| August 19, 2026 | NCT07772466 | Atherosclerosis in Early Rheumatoid Arthritis Patients Using Atherogenic Index of the Plasma and Carotid Intima Media Thickness | Assiut University | Observational | Not yet recruiting | Atheroscleroses, Rheumatoid Arthritis (RA | 70 | clinicaltrials.gov | |
| August 18, 2026 | NCT07769619 | Integrative AI-Based Multiomic and Neurophysiological Profiling of Chronic Pain in Rheumatoid Arthritis | 4th Military Clinical Hospital with Polyclinic, Poland | Observational | Recruiting | Rheumatoid Arthritis (RA, Chronic Pain | 100 | Poland | clinicaltrials.gov |
| August 12, 2026 | NCT07761767 | Self-Care Education for Joint Stiffness and Functional Ability in Rheumatoid Arthritis | Assiut University | Not applicable | Not yet recruiting | Rheumatoid Arthritis (RA) | 110 | clinicaltrials.gov | |
| August 12, 2026 | NCT07760662 | Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis | University of La Laguna | Observational | Recruiting | Rheumatoid Arthritis (RA, Oxidative Stress, Cardiovascular (CV) Risk | 200 | Spain | clinicaltrials.gov |
| August 10, 2026 | NCT07754552 | Development and Evaluation of the Effectiveness of the SMART-HAND Protocol for Hand Rehabilitation in Patients With Rheumatoid Arthritis | Istanbul University - Cerrahpasa | Not applicable | Not yet recruiting | Rheumatoid Arthritis, Rheumatoid Arthritis (RA, Rheumatoid Arthritis (RA) Prevention | 132 | clinicaltrials.gov | |
| August 6, 2026 | NCT07748728 | TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs | Hangzhou Highlightll Pharmaceutical Co., Ltd | Phase 2 | Enrolling by invitation | Rheumatoid Arthritis (RA) | 90 | China | clinicaltrials.gov |
| August 4, 2026 | NCT07745426 | Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis | Tanta University | Phase 2 | Recruiting | Rheumatoid Arthritis (RA) | 66 | Egypt | clinicaltrials.gov |
| August 4, 2026 | NCT07744828 | A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants | Dr. Reddy's Laboratories Limited | Phase 1 | Not yet recruiting | Healthy Volunteers | 160 | New Zealand | clinicaltrials.gov |
| July 31, 2026 | NCT07740200 | Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional... | Synovo Ltd. | Observational | Completed | Rheumatoid Arthritis (RA) | 61 | Pakistan | clinicaltrials.gov |
| July 30, 2026 | NCT07737470 | Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Pericarditis, Tako-TSUBO Cardiomyopathy, Myocarditis, Inflammatory Cardiomyopathies, Lupus, Systemic Sclerosis... | 300 | clinicaltrials.gov | |
| July 30, 2026 | NCT07737119 | Impact of Optimised Protein Intake on Household Work Limitations and Disability in Rheumatoid Arthritis | Satguru Partap Singh Hospitals | Not applicable | Completed | Rheumatoid Arthritis (RA) | 120 | India | clinicaltrials.gov |
| July 28, 2026 | NCT07730723 | The Effect of Nicorandil on Rheumatoid Arthritis Patients | Ain Shams University | Phase 2/3 | Recruiting | Rheumatoid Arthritis (RA) | 70 | Egypt | clinicaltrials.gov |
| July 28, 2026 | NCT07729995 | BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease | Luminary Therapeutics | Phase 1 | Not yet recruiting | Rheumatoid Arthritis (RA), Systemic Lupus Erthematosus (SLE), Dermatomyositis (DM), Systemic Sclerosis (SSc) | 94 | United States | clinicaltrials.gov |
| July 24, 2026 | NCT07726355 | A Randomized Clinical Trial Evaluating the Efficacy of Clinical Pharmacist Assistance Along With Pharmaceutical and Non-pharmaceutical... | Deraya University | Phase 2/3 | Completed | Early Rheumatoid Arthritis | 70 | Egypt | clinicaltrials.gov |
| July 22, 2026 | NCT07721142 | Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis | Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine | Phase 4 | Recruiting | Rheumatoid Arthritis (RA) | 300 | China | clinicaltrials.gov |
| July 20, 2026 | NCT07715045 | Umbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid Arthritis | Universitas Sriwijaya | Phase 2 | Completed | Rheumatoid Arthritis | 40 | Indonesia | clinicaltrials.gov |
| July 20, 2026 | NCT07712939 | A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases | Candid Therapeutics | Phase 1 | Recruiting | Healthy Participants Study, Rheumatoid Arthritis, Sjogren's Syndrome | 105 | Australia | clinicaltrials.gov |
| July 16, 2026 | NCT07709312 | the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients | Ain Shams University | Phase 2/3 | Not yet recruiting | Rheumatoid Arthritis (RA), Manegmentof Rheumatoid Arthritis | 50 | clinicaltrials.gov | |
| July 15, 2026 | NCT07704580 | Phase 1b/2 Study of IV Sarilumab in Adult With RA | Sanofi | Phase 1/2 | Recruiting | Rheumatoid Arthritis | 140 | United States | clinicaltrials.gov |
| July 6, 2026 | NCT07684157 | A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis | Jacobio Pharmaceuticals Co., Ltd. | Phase 2 | Recruiting | Rheumatoid Arthritis (RA) | 32 | China | clinicaltrials.gov |
| July 2, 2026 | NCT07680101 | Intra-Articular Adelmidrol 2%/Hyaluronic Acid 1% With or Without m/umPEA, in Knee Pain Due to Joint Degeneration. | Universita di Verona | Not applicable | Not yet recruiting | Degenerative Joint Disease of Knee, Rheumatoid Arthritis | 80 | Italy | clinicaltrials.gov |
| July 1, 2026 | NCT07678112 | Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy | Francisco J. Blanco | Not applicable | Recruiting | Rheumatoid Arthritis (RA) | 184 | Spain | clinicaltrials.gov |
| July 1, 2026 | NCT07678034 | Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Shoulder Prosthesis System | TIPMED Medical Device Manufacturing Ltd. Co. | Observational | Recruiting | Glenohumeral Osteoarthritis, Proximal Humerus Fracture, Rotator Cuff Arthropathy, Rheumatoid Arthritis, Avascular... | 54 | Turkey (Türkiye) | clinicaltrials.gov |
| June 30, 2026 | NCT07675226 | Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions | Oscotec Inc. | Phase 1 | Active not recruiting | Bioequivalence Study in Healthy Subjects, Immune Thrombocytopenia (ITP), Rheumatoid Arthritis (RA) | 48 | South Korea | clinicaltrials.gov |
| June 29, 2026 | NCT07674134 | Comparison of Oral Administration of a JAK Inhibitor in Rheumatoid Arthritis | Centre Hospitalier Princesse Grace | Observational | Recruiting | Rheumatoid Arthritis (RA) | 90 | Monaco | clinicaltrials.gov |
| June 24, 2026 | NCT07666594 | Mobile App-Based Yoga and Meditation in Rheumatoid Arthritis | Tugba Civi Karaaslan | Not applicable | Not yet recruiting | Rheumatoid Arthritis (RA), Anxiety, Depression Anxiety Disorder, Mobile Health Technology (mHealth) | 102 | Turkey (Türkiye) | clinicaltrials.gov |
| June 22, 2026 | NCT07660029 | BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote Monitoring in... | University of Ulster | Observational | Recruiting | Rheumatoid Arthritis (RA), Remote Patient Monitoring | 20 | United Kingdom | clinicaltrials.gov |
| June 18, 2026 | NCT07657156 | Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty Arthritis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis (RA), Gouty Arthritis (GA), Gout, Inflammatory Arthritis | 100 | clinicaltrials.gov | |
| June 16, 2026 | NCT07649265 | A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 | Recruiting | Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Sjögren's Disease | 63 | Australia | clinicaltrials.gov |
| June 12, 2026 | NCT07646470 | Effects of Chronic Non-invasive Vagus Nerve Stimulation in an Asplenic Individual Suffering From Rheumatoid Arthritis | Osteoflow Health Clinic | Not applicable | Completed | Rheumatoid Arthritis (RA | 1 | Canada | clinicaltrials.gov |
| June 12, 2026 | NCT07646262 | Gluten-Free vs Mediterranean Diet in Rheumatoid Arthritis | Hasan Kalyoncu University | Not applicable | Recruiting | Rheumatoid Arthritis (RA | 66 | Turkey (Türkiye) | clinicaltrials.gov |
| June 10, 2026 | NCT07639177 | Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis | Peking Union Medical College Hospital | Phase 2 | Recruiting | Rheumatoid Arthritis | 40 | China | clinicaltrials.gov |
| June 9, 2026 | NCT07636057 | Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis | Sheikh Zayed Federal Postgraduate Medical Institute | Phase 4 | Not yet recruiting | Rheumatoid Arthritis (RA) | 100 | clinicaltrials.gov | |
| June 8, 2026 | NCT07632872 | Desloratadine as Adjunct Therapy for Rheumatoid Arthritis | Horus University | Phase 2 | Recruiting | Rheumatoid Arthritis (RA), Rheumatoid Arthritis | 60 | Egypt | clinicaltrials.gov |
| June 8, 2026 | NCT07632846 | Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis | Horus University | Phase 2 | Recruiting | Rheumatoid Arthritis, Rheumatoid Arthritis (RA) | 50 | Egypt | clinicaltrials.gov |
| June 4, 2026 | NCT07627893 | Complementary Herbal Approach to Rheumatoid Management Study (CHARMS) | Singapore General Hospital | Phase 2/3 | Recruiting | Rheumatoid Arthritis (RA) | 132 | Singapore | clinicaltrials.gov |
| June 4, 2026 | NCT07627542 | An Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals... | Merve Şahin | Observational | Recruiting | Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Forward Head Posture | 111 | Turkey (Türkiye) | clinicaltrials.gov |
| June 3, 2026 | NCT07624994 | Functional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear Medicine | Centre Jean Perrin | Phase 2 | Not yet recruiting | Digital Osteoarthritis or Rheumatoid Arthritis | 80 | France | clinicaltrials.gov |
| June 2, 2026 | NCT07620392 | An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis | Hoffmann-La Roche | Phase 2 | Recruiting | Rheumatoid Arthritis | 120 | Brazil, Poland, United States | clinicaltrials.gov |
| May 28, 2026 | NCT07611747 | Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) | Instituto de Investigación Marqués de Valdecilla | Phase 4 | Recruiting | Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE), Caridovascular... | 1,944 | Spain | clinicaltrials.gov |
| May 27, 2026 | NCT07607964 | A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous... | AbbVie | Phase 1 | Recruiting | Systemic Lupus Erythematosus, Rheumatoid Arthritis | 30 | Japan, United States | clinicaltrials.gov |
| May 20, 2026 | NCT07598240 | Is a Standard Hand Rehabilitation Program Sufficient in Rheumatoid Arthritis Patients With Central Sensitization | Fulya Coşkun | Not applicable | Active not recruiting | Hand Exercises for Rheumatoid Arthritis | 81 | Turkey (Türkiye) | clinicaltrials.gov |
| May 18, 2026 | NCT07593911 | A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases | Beijing GoBroad Hospital | Not applicable | Not yet recruiting | Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN), Multiple Sclerosis, Myasthenia Gravis (MG), IgG4-Related... | 75 | China | clinicaltrials.gov |
| May 12, 2026 | NCT07582185 | Tdose Binding and Tocilizumab | Centre Hospitalier Universitaire de Nice | Phase 4 | Not yet recruiting | Rheumatoid Arthritis | 122 | France | clinicaltrials.gov |
| May 12, 2026 | NCT07580092 | Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease | Karolinska Institutet | Observational | Completed | Ankylosing Spondylitis, Rheumatoid Arthritis (RA), Psoriatic Arthritis, Polyarthritis, Inflammatory Joint Disease (IJD) | 6,967 | Sweden | clinicaltrials.gov |
| May 7, 2026 | NCT07571993 | Rheumatoid Arthritis Remission Screening and Prospective Surveillance | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Rheumatoid Arthritis | 200 | Italy | clinicaltrials.gov |
| May 5, 2026 | NCT07566351 | Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis | Horus University | Phase 2 | Recruiting | Rheumatoid Arthritis | 90 | Egypt | clinicaltrials.gov |
| May 4, 2026 | NCT07564154 | A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA) | Kali Therapeutics, Inc. | Phase 1 | Recruiting | Rheumatoid Arthritis (RA) | 27 | Australia, New Zealand | clinicaltrials.gov |
| April 30, 2026 | NCT07558850 | Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases | The First Affiliated Hospital with Nanjing Medical University | Not applicable | Recruiting | Rheumatoid Arthritis, Dermatomyositis, Systemic Lupus Erythematosus, Systemic Sclerosis | 72 | China | clinicaltrials.gov |
| April 28, 2026 | NCT07554820 | Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With... | Shaikh Zayed Hospital, Lahore | Phase 4 | Recruiting | Rheumatoid Arthritis, Major Adverse Cardiac Events | 120 | Pakistan | clinicaltrials.gov |
| April 28, 2026 | NCT07553871 | Comparative Study on the Medium- and Long-term Benefits of Prosthesis Selection in Total Knee Arthroplasty | Second Affiliated Hospital of Wenzhou Medical University | Observational | Not yet recruiting | Knee Osteoarthritis, Rheumatoid Arthritis (RA) | 3,500 | clinicaltrials.gov | |
| April 22, 2026 | NCT07544225 | Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic... | Gustave Roussy, Cancer Campus, Grand Paris | Phase 1 | Not yet recruiting | Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Sjogren's Disease With Dry Eyes, Systemic Sclerosis... | 6 | France | clinicaltrials.gov |
| April 17, 2026 | NCT07536529 | Oxidative Stress in Autoimmune Rheumatic Diseases | University of Thessaly | Observational | Recruiting | Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) | 200 | Greece | clinicaltrials.gov |
| April 16, 2026 | NCT07534332 | Disulfiram in Rheumatoid Arthritis | University of Oklahoma | Phase 2 | Not yet recruiting | Rheumatoid Arthritis, Inflammation, Obesity | 20 | United States | clinicaltrials.gov |
| April 14, 2026 | NCT07527936 | A Study of BEN301 Injection in theTreatment of Autoimmune Diseases | RenJi Hospital | Early phase 1 | Suspended | Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), Sjogren's Syndrome (SS), Idiopathic Inflammatory Myopathies(IIM) | 24 | China | clinicaltrials.gov |
| April 13, 2026 | NCT07525856 | Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis | CHU de Quebec-Universite Laval | Not applicable | Not yet recruiting | Rheumatoid Arthritis (RA) | 104 | Canada | clinicaltrials.gov |
| April 13, 2026 | NCT07524244 | Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis | Fuller Research Foundation | Not applicable | Recruiting | Rheumatoid Arthritis (RA), Crohn's Disease (CD), Ulcerative Colitis (UC) | 160 | United States | clinicaltrials.gov |
| April 7, 2026 | NCT07515638 | Immun4Cure Cohort of Autoimmune Diseases | University Hospital, Montpellier | Observational | Recruiting | Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Healthy Adult Volunteers | 500 | France | clinicaltrials.gov |
| March 27, 2026 | NCT07497282 | Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis | Ain Shams University | Phase 2 | Not yet recruiting | Rheumatoid Arthritis | 70 | clinicaltrials.gov | |
| March 24, 2026 | NCT07491016 | Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis | Zhejiang Provincial People's Hospital | Observational | Recruiting | Telitacicept, Treatment Compliance, Rheumatoid Arthritis | 30 | China | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Assiut University | 16 | September 24, 2026 |
| Sohag University | 9 | October 16, 2026 |
| Tanta University | 7 | October 28, 2026 |
| Peking University People's Hospital | 6 | September 1, 2026 |
| Ain Shams University | 5 | July 28, 2026 |
| AbbVie | 4 | October 29, 2026 |
| AstraZeneca | 4 | December 22, 2025 |
| Novartis Pharmaceuticals | 3 | November 6, 2026 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 3 | November 4, 2026 |
| Zhejiang Provincial People's Hospital | 3 | October 28, 2026 |
| Merck Sharp & Dohme LLC | 3 | October 26, 2026 |
| Bristol-Myers Squibb | 3 | October 14, 2026 |
| University of Bonn | 3 | August 19, 2026 |
| Horus University | 3 | June 8, 2026 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 | January 16, 2026 |
| Eli Lilly and Company | 3 | December 11, 2025 |
| Université Catholique de Louvain | 3 | June 3, 2025 |
| Kirsehir Ahi Evran Universitesi | 3 | January 10, 2025 |
| Shanghai Qilu Pharmaceutical Research and Development Center LTD | 2 | October 30, 2026 |
| University of Baghdad | 2 | October 29, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Observational | 95 | November 4, 2026 |
| Not applicable | 79 | November 4, 2026 |
| Phase 1 | 44 | November 6, 2026 |
| Phase 2 | 36 | October 29, 2026 |
| Phase 4 | 19 | September 3, 2026 |
| Phase 1/2 | 13 | October 28, 2026 |
| Early phase 1 | 8 | April 14, 2026 |
| Phase 2/3 | 5 | July 28, 2026 |
| Phase 3 | 3 | September 2, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| China | 58 | November 4, 2026 |
| United States | 45 | October 16, 2026 |
| Turkey (Türkiye) | 34 | November 4, 2026 |
| Egypt | 28 | October 28, 2026 |
| Germany | 25 | October 14, 2026 |
| France | 24 | October 14, 2026 |
| Spain | 20 | August 12, 2026 |
| Poland | 15 | October 14, 2026 |
| Australia | 13 | July 20, 2026 |
| Brazil | 10 | August 19, 2026 |
| Italy | 10 | July 2, 2026 |
| Canada | 10 | June 12, 2026 |
| Belgium | 9 | October 14, 2026 |
| United Kingdom | 9 | June 22, 2026 |
| Georgia | 8 | August 21, 2026 |
| Japan | 8 | May 27, 2026 |
| Moldova | 7 | February 25, 2026 |
| Romania | 6 | February 25, 2026 |
| Ukraine | 6 | February 17, 2026 |
| Netherlands | 5 | October 14, 2026 |
| Denmark | 5 | September 17, 2026 |
| Argentina | 5 | January 28, 2026 |
| Bulgaria | 5 | December 11, 2025 |
| Czechia | 5 | September 15, 2025 |
| South Korea | 4 | September 18, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.